380 related articles for article (PubMed ID: 17294457)
1. Assessment of developmental toxicity of vorinostat, a histone deacetylase inhibitor, in Sprague-Dawley rats and Dutch Belted rabbits.
Wise LD; Turner KJ; Kerr JS
Birth Defects Res B Dev Reprod Toxicol; 2007 Feb; 80(1):57-68. PubMed ID: 17294457
[TBL] [Abstract][Full Text] [Related]
2. Assessment of female and male fertility in Sprague-Dawley rats administered vorinostat, a histone deacetylase inhibitor.
Wise LD; Spence S; Saldutti LP; Kerr JS
Birth Defects Res B Dev Reprod Toxicol; 2008 Feb; 83(1):19-26. PubMed ID: 18092367
[TBL] [Abstract][Full Text] [Related]
3. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
Fedier A; Dedes KJ; Imesch P; Von Bueren AO; Fink D
Int J Oncol; 2007 Sep; 31(3):633-41. PubMed ID: 17671692
[TBL] [Abstract][Full Text] [Related]
4. Conduct and interpretation of a dermal developmental toxicity study with KBR 3023 (a prospective insect repellent) in the Sprague-Dawley rat and Himalayan rabbit.
Astroff AB; Young AD; Holzum B; Sangha GK; Thyssen JH
Teratology; 2000 Mar; 61(3):222-30. PubMed ID: 10661912
[TBL] [Abstract][Full Text] [Related]
5. Developmental toxicity evaluation of sodium thioglycolate administered topically to Sprague-Dawley (CD) rats and New Zealand White rabbits.
Tyl RW; Price CJ; Marr MC; Myers CB; van Birgelen AP; Jahnke GD
Birth Defects Res B Dev Reprod Toxicol; 2003 Apr; 68(2):144-61. PubMed ID: 12866706
[TBL] [Abstract][Full Text] [Related]
6. Monomethylarsonic acid and dimethylarsinic acid: developmental toxicity studies with risk assessment.
Irvine L; Boyer IJ; DeSesso JM
Birth Defects Res B Dev Reprod Toxicol; 2006 Feb; 77(1):53-68. PubMed ID: 16496296
[TBL] [Abstract][Full Text] [Related]
7. Safety assessment of DHA-rich microalgae from Schizochytrium sp.
Hammond BG; Mayhew DA; Holson JF; Nemec MD; Mast RW; Sander WJ
Regul Toxicol Pharmacol; 2001 Apr; 33(2):205-17. PubMed ID: 11350203
[TBL] [Abstract][Full Text] [Related]
8. The role of maternal toxicity in lovastatin-induced developmental toxicity.
Lankas GR; Cukierski MA; Wise LD
Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):111-23. PubMed ID: 15282732
[TBL] [Abstract][Full Text] [Related]
9. Developmental toxicity of the HMG-CoA reductase inhibitor, atorvastatin, in rats and rabbits.
Dostal LA; Schardein JL; Anderson JA
Teratology; 1994 Dec; 50(6):387-94. PubMed ID: 7778043
[TBL] [Abstract][Full Text] [Related]
10. Nonclinical safety assessment of the histone deacetylase inhibitor vorinostat.
Kerr JS; Galloway S; Lagrutta A; Armstrong M; Miller T; Richon VM; Andrews PA
Int J Toxicol; 2010; 29(1):3-19. PubMed ID: 19903873
[TBL] [Abstract][Full Text] [Related]
11. Developmental toxicity evaluation of emodin in rats and mice.
Jahnke GD; Price CJ; Marr MC; Myers CB; George JD
Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):89-101. PubMed ID: 15098202
[TBL] [Abstract][Full Text] [Related]
12. Developmental toxicity evaluation of triclopyr butoxyethyl ester and triclopyr triethylamine salt in the CD rat.
Carney EW; Billington R; Barlow SM
Reprod Toxicol; 2007 Feb; 23(2):165-74. PubMed ID: 17194567
[TBL] [Abstract][Full Text] [Related]
13. Embryo/fetal toxicity assessment of lasofoxifene, a selective estrogen receptor modulator (SERM), in rats and rabbits.
Ozolins TR; Gupta U
Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):161-70. PubMed ID: 15282737
[TBL] [Abstract][Full Text] [Related]
14. Developmental toxicity evaluation of butylparaben in Sprague-Dawley rats.
Daston GP
Birth Defects Res B Dev Reprod Toxicol; 2004 Aug; 71(4):296-302. PubMed ID: 15334527
[TBL] [Abstract][Full Text] [Related]
15. Different embryo-fetal toxicity effects for three VLA-4 antagonists.
Crofts F; Pino M; DeLise B; Guittin P; Barbellion S; Brunel P; Potdevin S; Bergmann B; Hofmann T; Lerman S; Clark RL
Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):55-68. PubMed ID: 15098199
[TBL] [Abstract][Full Text] [Related]
16. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
[TBL] [Abstract][Full Text] [Related]
17. Developmental toxicity and toxicokinetics of two endothelin receptor antagonists in rats and rabbits.
Treinen KA; Louden C; Dennis MJ; Wier PJ
Teratology; 1999 Jan; 59(1):51-9. PubMed ID: 9988883
[TBL] [Abstract][Full Text] [Related]
18. Developmental toxicity and uterotrophic studies with di-2-ethylhexyl terephthalate.
Faber WD; Deyo JA; Stump DG; Navarro L; Ruble K; Knapp J
Birth Defects Res B Dev Reprod Toxicol; 2007 Oct; 80(5):396-405. PubMed ID: 17849488
[TBL] [Abstract][Full Text] [Related]
19. Developmental toxicity of thiodiglycol in Sprague-Dawley rats.
Houpt JT; Crouse LC; Angerhofer RA; Leach GJ; Reddy G
Int J Toxicol; 2007; 26(4):365-71. PubMed ID: 17661228
[TBL] [Abstract][Full Text] [Related]
20. Developmental and reproductive toxicity evaluation of toluene vapor in the rat II. Developmental toxicity.
Roberts LG; Nicolich MJ; Schreiner CA
Reprod Toxicol; 2007 Jun; 23(4):521-31. PubMed ID: 17360154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
